Epstein-Barr virus (EBV) infects two cell types, B lymphocytes and epithelial cells. Electron microscopic studies have shown that the virus fuses with the lymphoblastoid cell line Raji but is endocytosed into thin-walled non-clathrin-coated vesicles in normal B cells before fusion takes place. To compare early interactions of EBV with epithelial cells and B cells, a fluorescence dequenching assay of fusion was employed, using virus labeled either with the pH-insensitive probe octadecyl rhodamine B chloride (R18) or with 5(N-octadecanoyl) aminofluorescein (AF), which loses emission intensity at a pH below 7. Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that is implicated in diseases involving infection of two cell types, B lymphocytes and epithelial cells. The virus causes infectious mononucleosis (10), is associated with B-cell neoplasia (4) and nasopharyngeal carcinoma (5), and induces oral hairy leukoplakia in AIDS patients (8). Infection of the B cell is initiated by attachment of virus to the type 2 complement receptor, CR2 or CD21 (6, 20) , and a similar, but probably not identical, molecule may be responsible for binding of virus to the epithelial cell (26, 31). Penetration of the virus through the B-cell membrane can then apparently take one of two routes. Analyses of virus entry by electron microscopy indicated that EBV fuses directly with the plasmalemma of the lymphoblastoid cell line Raji, but that it is endocytosed into thin-walled non-clathrin-coated vesicles before it fuses with normal B cells (18, 24) . Further studies with immunotoxins bound to the EBV receptor supported these observations by demonstrating that CD21 is internalized with virus entering freshly isolated B cells but not with virus infecting Raji cells (28). Although a complete understanding of the pathogenesis of EBV-induced disease clearly requires knowledge of the infectious process in all cells that the virus infects, nothing is known about how virus penetrates the epithelial cell.
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that is implicated in diseases involving infection of two cell types, B lymphocytes and epithelial cells. The virus causes infectious mononucleosis
, is associated with B-cell neoplasia (4) and nasopharyngeal carcinoma (5) , and induces oral hairy leukoplakia in AIDS patients (8) . Infection of the B cell is initiated by attachment of virus to the type 2 complement receptor, CR2 or CD21 (6, 20) , and a similar, but probably not identical, molecule may be responsible for binding of virus to the epithelial cell (26, 31) . Penetration of the virus through the B-cell membrane can then apparently take one of two routes. Analyses of virus entry by electron microscopy indicated that EBV fuses directly with the plasmalemma of the lymphoblastoid cell line Raji, but that it is endocytosed into thin-walled non-clathrin-coated vesicles before it fuses with normal B cells (18, 24) . Further studies with immunotoxins bound to the EBV receptor supported these observations by demonstrating that CD21 is internalized with virus entering freshly isolated B cells but not with virus infecting Raji cells (28) . Although a complete understanding of the pathogenesis of EBV-induced disease clearly requires knowledge of the infectious process in all cells that the virus infects, nothing is known about how virus penetrates the epithelial cell.
The fact that EBV can fuse directly at the cell surface of Raji cells at neutral pH would suggest that the fusion process is pH independent. However, lysosomotropic agents such as chloroquine and ammonium chloride have been reported to reduce EBV infectivity (18) , and calmodulin antagonists that inhibit endocytosis also block EBV infection of normal B cells (19) . There is thus some uncertainty about the require-33136.
ments for virus-cell fusion. Does virus fuse more efficiently from a low-pH environment, is the thin-walled endocytic vesicle from which EBV fuses actually acidified, and is the Raji cell unique in its ability to fuse with EBV at the cell surface? Recently developed fluorescence dequenching assays which allow real-time measurement of virus fusion in isolation from the events that precede or follow it provide a new approach with which to examine these questions (11, 12) . Amphophilic fluorophores are incorporated into virus membranes at the high concentrations at which they are self-quenching. When virus and cells fuse, there is a measurable relief of self-quenching and an increase in fluorescence that can be monitored kinetically. We initially used the pH-insensitive probe octadecyl rhodamine B chloride (R18) to measure the rate of EBV fusion with B cells and determine the involvement of one of the EBV proteins, gp85, in the process (9, 15) . The availability of a second probe, 5(N-octadecanoyl) aminofluorescein (AF), which significantly loses emission intensity at a pH below 7.4, suggested to us that a combination of R18-and AF-labeled virus might be used to determine the pH of the environment in which EBV fuses and examine whether or Lysosomotropic agents and cellular inhibitors. Stock solutions of ammonium chloride (100 mM), chloroquine (100 mM), methylamine (50 mM), and sodium azide (100 mM) were prepared in PBS. A 5 mM stock of chlorpromazine was prepared in PBS with 1% dimethyl sulfoxide. All working dilutions were made in RPMI 1640. All reagents were purchased from Sigma. Cells were preincubated with 500 pd of each reagent for 35 min at 37°C and pelleted by centrifugation at 400 x g for 5 min, and all but 100 pul of supernatant was removed. Fifty microliters of virus was added, and cells were incubated for 1 h on ice. Unbound virus was removed by washing cells three times in PBS, and cells and bound virus were transferred to the fluorometer.
Determination of intracellular pH. The pH in endocytic compartments was measured by modification of published methods (7, 21, 29) . Cells were incubated with fluorescein isothiocyanate (FITC)-and tetramethylrhodamine (TRITC)-labeled dextrans (70,000 molecular weight; Molecular Probes) for 35 min at 37°C to allow uptake into cells. Cells were washed free of unassociated dextran and analyzed in the spectrofluorometer by measuring the TRITC fluorescence at an excitation wavelength of 560 nm and an emission wavelength of 580 nm, followed by measuring FITC emission at 522 nm at excitation wavelengths from 450 to 518 nm. Fluorescence was expressed in arbitrary units. Monensin (Sigma; 1 pug/ml) was then added to equilibrate extracellular (known pH) and endosomal pH, and another measurement of FITC fluorescence was made. A change in the intensity of the FITC fluorescence was assumed to indicate that the average pH of the intracellular compartment was either above (increase) or below (decrease) the known extracellular pH; if no change in fluorescence was observed, the intracellular and extracellular pH were assumed to be the same. (Fig. 1) , and identical results were obtained with concentrations of up to 1 mM methylamine (data not shown). However, a third lysosomotropic agent, chloroquine, had no effect on the dequenching of virus bound to Raji cells ( Fig. 2A) or epithelial cells (Fig. 2D ) but inhibited dequenching of virus bound to normal B cells and BAT cells in a dose-dependent manner (Fig. 2B and C) .
RESULTS
The fact that only one lysosomotropic agent affected entry of EBV raised concern as to whether each of them had actually affected intracellular pH. Endosomal pH was therefore measured in treated and untreated cells, using TRITC- and FITC-dextran. The emission of TRITC-dextran is unaffected by pH and can be used as an internal control for uptake of dextran. In contrast, the emission of FITC-dextran decreases as the pH of the environment decreases. Fluorescence emission at 522 nm was measured for BAT cells that had endocytosed a mixture of FITC-and TRITC-dextran. Emission from untreated cells was low and increased significantly after addition of monensin to collapse the intracellular pH gradient and raise the internal pH to that of the external buffer at pH 7.4 (Fig. 3A) . When cells were pretreated with 20 mM ammonium chloride, fluorescence emission at 522 nm was much higher than that of the untreated cells, although addition of monensin still resulted in a slight increase in signal (Fig. 3B) . When the pH of the extracellular medium was reduced to 7.0, addition of monensin to pretreated cells had no effect on emission at 522 nm, indicating that ammonium chloride had raised the endosomal pH to this value (Fig. 3C ). Similar experiments with methylamine and chloroquine indicated that these reagents also raised endosomal pH to approximately 7.0 (data not shown). It (Fig. 5A ). These data suggested that a majority of virus fused with normal and recently transformed B cells from within an acidic compartment, whereas fusion with the epithelial cell, like fusion with Raji, occurred at neutral pH. Effect of inhibitors of endocytosis on dequenching. All three of the lysosomotropic agents studied had raised intracellular pH, but only one, chloroquine, had had any effect on dequenching of virus bound to normal B cells and BAT cells. Since chloroquine was also the only agent that affected uptake of dextran into cells, we considered the possibility that its inhibitory effects were related to its effects on endocytosis. Two other reagents reported to inhibit endocytosis, sodium azide and chlorpromazine, were examined for their effects on dequenching of virus. Although neither drug had an effect on dequenching of virus bound to Raji cells or epithelial cells, both reduced dequenching of virus bound to normal B cells and BAT cells (Fig. 6 ). The effects of azide and chlorpromazine on endocytosis were confirmed by examining the uptake of TRITC-dextran into treated cells. Sodium azide at a concentration of 20 mM reduced dextran uptake into BAT cells by 40%; chlorpromazine at a concentration of 50 ,uM reduced dextran uptake by 82%. This result further suggested that the inhibition of endocytosis was correlated with failure of virus to fuse with normal B cells and BAT cells. Nemerow and Cooper (18) reported that methylamine, ammonium chloride, and chloroquine all affected EBV infectivity, but the reduction in infectivity that they observed with chloroquine far exceeded that for the other two agents (96% versus 16 and 20% inhibition). Furthermore, the point after attachment at which the reagents influenced infectivity was determined for chloroquine alone, and the possibility that the other two reagents affected cell metabolism rather than virus entry cannot be ruled out. The electron microscopic studies of Nemerow and Cooper (18) indicated that chloroquine inhibited penetration of virus through the endocytic vesicle membrane. They observed no effect of drug on the formation of endocytic vesicles. In contrast, however, our fluorescence studies suggest that chloroquine affected the extent of endocytosis and are in agreement with reports that at concentrations exceeding 0.1 mM, it can influence uptake of molecules into cells (1) . The fact that two other drugs, chlorpromazine and sodium azide, coincidentally influenced endocytosis and fluorescence dequenching in normal B cells raises the possibility that in this cell type, endocytosis is actually required for fusion to take place. Sodium azide is an inhibitor of oxidative phosphorylation that has been shown to affect uptake of Semliki Forest virus (13) and vesicular stomatitis virus (2) . Chlorpromazine is a phenothiazine that binds to calmodulin and has been reported to inhibit formation of large thin-walled vesicles (23) morphologically similar to those into which EBV is endocytosed (18) . Indeed, several phenothiazines and other classes of calmodulin antagonists have been reported to influence endocytosis and infection by EBV (19) . Whether the impairment of fusion of virus with the surface of normal B cells is due to the lack of an essential component in the plasmalemma or to the presence of an inhibitory factor is unclear.
The contrasting failure of chlorpromazine, chloroquine, and sodium azide to affect dequenching of virus bound to Raji cells and epithelial cells correlated with the observation that little if any enveloped virus entered an acidified cell compartment in either of these cells and further suggests that virus penetrates not only Raji cells but also epithelial cells by direct fusion with the plasmalemma. This conclusion should be tempered by two caveats. First, dequenching assays of fusion provide information about the behavior of a population of virions, both infectious and noninfectious, not about individual particles. Thus, it is fair only to say that a majority of EBV virions behave in a given fashion. Second, the epithelial tissue used was in an unnaturally nonpolarized and dispersed state. This concern is, however, somewhat mitigated by the fact that such dispersed cells are infectable with EBV (25) .
It has been suggested that abnormalities in the cytoskeleton of malignant cells, such as Raji, are responsible for the discrepancy between the route that EBV takes into the B-lymphoma line and its normal counterparts (18, 27) . It seems plausible that the superficially similar route that EBV takes into epithelial cells may also reflect the nature of the integration of membrane and cytoskeleton. CR2 is the ligand-binding subunit of a signal transduction complex in the membrane of the B cell which is composed of a number of poorly characterized molecules and the B-cell-specific protein, CD19 (14) . Binding of the EBV attachment protein gp350/220 to CR2 has been reported to induce capping in association with surface immunoglobulin and endocytosis (27) ; the cytoplasmic tail of CR2 is essential to this process (3). The identity of the EBV receptor on epithelial cells is uncertain, but irrespective of whether or not it is a CR2-related molecule, it clearly does not associate with a complex incorporating CD19 or co-cap with immunoglobulin on this cell type, and its interface with the cytoskeleton may be quite different from that of CR2. The apparently disparate routes that EBV takes into epithelial cells and B cells may have considerable significance for the subsequent fate of nucleocapsids in each cell type and for the route(s) and mechanisms responsible for intracellular transport to the nucleus, and they reinforce the important point that the biological aspects of infection of these two cell types are quite different.
